(This lecture is part of our Psychodermatology: New Frontiers For Treating Stress-Driven Skin Conditions)
Target Audience: This lecture is intended for a general audience, including healthcare professionals, patients with Chronic Spontaneous Urticaria (CSU) and their families, as well as anyone interested in understanding the impact of psychological factors on physical health. It aims to shed light on the complex interplay between childhood trauma, attachment styles, and their potential influence on chronic health conditions like CSU, making it accessible and informative for both medical and non-medical attendees.
Learning Objectives: Attendees will gain insights into the following areas:
- Understanding CSU: An overview of Chronic Spontaneous Urticaria, including its symptoms, challenges in treatment, and the significance of identifying non-traditional triggers.
- Psychological Determinants: How childhood trauma and maladaptive attachment styles can potentially interfere with the neuro-immuno-cutaneous-endocrine system, influencing the pathophysiology of CSU.
- Research Findings: Key results from a recent case-control study that investigates the association between CSU, childhood trauma, and attachment styles, including statistical evidence of higher incidences of physical neglect and avoidant attachment in CSU patients.
- Impact on Quality of Life: Insights into how emotional abuse, sexual abuse, and anxious-ambivalent attachment styles correlate with an elevated Chronic Urticaria Quality of Life Index (CU-QLI) score among CSU patients.
- Holistic Approach to Management: The importance of a multidisciplinary approach to effectively manage CSU, considering both medical treatment and psychological support to address the root causes and improve patients’ quality of life.
By attending this lecture, participants will gain a deeper understanding of the potential links between chronic illnesses like CSU and psychological factors, emphasizing the need for a comprehensive approach to treatment that goes beyond conventional medical therapies.